| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000006539 |
| Receipt No. | R000007750 |
| Official scientific title of the study | Trail against hyperlipidemia patients with high risks to investigate the effect on small dense LDL-C & IDL by using middle dose Rosuvastatin in Saitama |
| Date of disclosure of the study information | 2011/11/07 |
| Last modified on | 2017/09/27 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | Trail against hyperlipidemia patients with high risks to investigate the effect on small dense LDL-C & IDL by using middle dose Rosuvastatin in Saitama | |
| Title of the study (Brief title) | PIONEER Saitama | |
| Region |
|
|
| Condition | ||
| Condition | Hyperlipidemia | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The lipid medical treatment by rosuvastatin to a high risk hyperlipidemia patient examines propriety aiming at disappearance of small dense LDL and IDL. The patients were estimated in 120 patients receiving coronary computed tomographic angiography (CCTA). |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Lipid profile (TC,TG,HDL-C, Friedewald LDL-C,small dense LDL,IDL),apo protein, apoE phenotype |
| Key secondary outcomes | Cr, BUN, Urinal analysis, GOT, GPT, CK, (following in the case of DM), fasting blood glucose, HbA1c. The coronary computed tomographic angiography (CCTA) was repeated and compared before and after treatment. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Rosuvastatin 5mg-20mg for 6 month | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)-3) 3 examine group
1)T2DM with 120 mg/dl or more than 120 mg/dl LDL-C 2)Patients of JAS Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2007 CategoryIII (Diabetes patients are excepted) with 120 mg/dl or more than 120 mg/dl LDL-C 3)Patients of JAS Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2007 Secondary prevention with 100 mg/dl or more than 100 mg/dl LDL-C |
|||
| Key exclusion criteria | A patient with the side-effects past in statin medication | |||
| Target sample size | 200 | |||
| Research contact person | |
| Name of lead principal investigator | Ikuo Inoue |
| Organization | Saitama Medical University |
| Division name | Dept. of Endocrinology and Diabetology |
| Address | 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama |
| TEL | 049-276-1875 |
| i1901018@saitama-med.ac.jp | |
| Public contact | |
| Name of contact person | Ikuo Inoue |
| Organization | Saitama Medical University |
| Division name | Dept. of Endocrinology and Diabetology |
| Address | 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama |
| TEL | 049-276-1875 |
| Homepage URL | |
| i1901018@saitama-med.ac.jp | |
| Sponsor | |
| Institute | Ikuo Inoue |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007750 |